These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 6746039)

  • 1. Immunological studies of multiple sclerosis.
    Maheshwari MC
    Indian J Med Res; 1984 Feb; 79():231-5. PubMed ID: 6746039
    [No Abstract]   [Full Text] [Related]  

  • 2. [The severity of disease and intensity of the immune response in multiple sclerosis].
    Schädlich HJ; Felgenhauer K; Schifferdecker M
    Nervenarzt; 1984 Aug; 55(8):441-3. PubMed ID: 6483066
    [No Abstract]   [Full Text] [Related]  

  • 3. CSF immunoglobulins G in multiple sclerosis.
    Caputo D; Zaffaroni M; Procaccia S
    Boll Ist Sieroter Milan; 1982; 61(5):393-403. PubMed ID: 6927183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IgG synthesis in the central nervous system in multiple sclerosis and other neurologic diseases. Measurement and validity].
    Safár J; Vymazal J; Tichý J; Růzicková V
    Cas Lek Cesk; 1985 Sep; 124(36):1131-6. PubMed ID: 4028102
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoglobulin G in the cerebrospinal fluid in patients with multiple sclerosis.
    Cendrowski W; Rosnowska M
    Acta Med Pol; 1979; 20(2):147-53. PubMed ID: 532700
    [No Abstract]   [Full Text] [Related]  

  • 6. [Function of the hemato-encephelic barrier and IgG synthesis in the central nervous system in multiple sclerosis and other neurologic disorders].
    Safár J; Vymazal J; Tichý J
    Cesk Neurol Neurochir; 1986 Nov; 49(6):382-9. PubMed ID: 3802248
    [No Abstract]   [Full Text] [Related]  

  • 7. [Local cerebrospinal fluid IgG production in multiple sclerosis].
    Schipper H
    Schriftenr Neurol; 1989; 30():1-91. PubMed ID: 2678429
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical analysis of 151 cases of multiple sclerosis].
    Xu ZC
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Dec; 17(6):377-81. PubMed ID: 6543728
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cerebrospinal fluid IgG and the blood-brain barrier in multiple sclerosis. A new viewpoint].
    Rüttinger H; Rüttinger P; Hermes M
    Nervenarzt; 1991 Feb; 62(2):127-9. PubMed ID: 2034308
    [No Abstract]   [Full Text] [Related]  

  • 10. No evidence for production of intrathecal immunoglobulin G against Acinetobacter or Pseudomonas in multiple sclerosis.
    Chapman MD; Hughes LE; Wilson CD; Namnyak S; Thompson EJ; Giovannoni G
    Eur Neurol; 2005; 53(1):27-31. PubMed ID: 15687729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early immunosuppressive effect of parenteral methylprednisolone in the treatment of multiple sclerosis.
    Durelli L; Baggio GF; Bergamasco B; Barile C; Cocito D; Delsedime M; Perla F; Riccio A; Bergamini L
    Acta Neurol (Napoli); 1985; 7(3-4):338-44. PubMed ID: 3904340
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cerebrospinal fluid findings in multiple sclerosis (author's transl)].
    Iwashita H; Matsumoto T; Kuroiwa Y
    Rinsho Byori; 1979 Jun; 27(6):486-90. PubMed ID: 470175
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical value of commonly used spinal fluid diagnostic studies in the evaluation of patients with suspected multiple sclerosis.
    Brasher GW; Follender AB; Spiekerman AM
    Am J Manag Care; 1998 Aug; 4(8):1119-21. PubMed ID: 10182887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.
    Di Pauli F; Mader S; Rostasy K; Schanda K; Bajer-Kornek B; Ehling R; Deisenhammer F; Reindl M; Berger T
    Clin Immunol; 2011 Mar; 138(3):247-54. PubMed ID: 21169067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles antibodies in multiple sclerosis patients.
    Caputo D; Ferrante P; Fasan M; Procaccia S
    Boll Ist Sieroter Milan; 1981; 60(1):57-60. PubMed ID: 7272013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple sclerosis as a sequela of measles?].
    Panelius M; Salmi AA
    Fortschr Med; 1972 May; 90(14):555-6. PubMed ID: 5072276
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoadsorption patients with multiple sclerosis: an open-label pilot study.
    Moldenhauer A; Haas J; Wäscher C; Derfuss T; Hoffmann KT; Kiesewetter H; Salama A
    Eur J Clin Invest; 2005 Aug; 35(8):523-30. PubMed ID: 16101673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in cerebrospinal fluid immunoglobulins during multiple sclerosis].
    Musiani P; Giovannini G; Pozzuoli R
    Riv Patol Nerv Ment; 1969 Apr; 90(2):99-112. PubMed ID: 5000385
    [No Abstract]   [Full Text] [Related]  

  • 19. [Subclasses of IgG in the cerebrospinal fluid oligoclonal bands of multiple sclerosis patients. Preliminary studies].
    Grimaldi LM; Maimone D; De Simone D; Finocchiaro AM; Reggio A
    Acta Neurol (Napoli); 1986 Jun; 8(3):221-5. PubMed ID: 3739768
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoglobulin abnormalities in multiple sclerosis.
    Link H
    Ann Clin Res; 1973 Oct; 5(5):330-6. PubMed ID: 4209372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.